X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4965) 4965
Newsletter (34) 34
Publication (7) 7
Magazine Article (4) 4
Book Chapter (3) 3
Newspaper Article (2) 2
Dissertation (1) 1
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hydroxyurea - pharmacology (4053) 4053
science & technology (2330) 2330
animals (2283) 2283
life sciences & biomedicine (2189) 2189
humans (2071) 2071
hydroxyurea (1075) 1075
mice (1003) 1003
female (930) 930
male (884) 884
cell line (634) 634
dna replication - drug effects (611) 611
dna - biosynthesis (608) 608
biochemistry & molecular biology (584) 584
cell biology (581) 581
time factors (555) 555
cells, cultured (550) 550
hydroxyurea - therapeutic use (502) 502
cell cycle (468) 468
kinetics (454) 454
rats (446) 446
dna damage (410) 410
dna replication (410) 410
pharmacology & pharmacy (405) 405
cell division - drug effects (392) 392
mutation (389) 389
hydroxyurea - analogs & derivatives (386) 386
thymidine - metabolism (363) 363
adult (359) 359
cell cycle - drug effects (335) 335
oncology (335) 335
tritium (335) 335
cytarabine - pharmacology (333) 333
dose-response relationship, drug (322) 322
ultraviolet rays (300) 300
antineoplastic agents - pharmacology (297) 297
hematology (291) 291
dna repair (288) 288
dna (283) 283
middle aged (281) 281
research article (271) 271
cell survival - drug effects (266) 266
research (258) 258
genetics & heredity (257) 257
hydroxyurea - administration & dosage (254) 254
cricetinae (251) 251
abridged index medicus (246) 246
cell division (229) 229
enzyme inhibitors - pharmacology (221) 221
phosphorylation (214) 214
cycloheximide - pharmacology (213) 213
dna repair - drug effects (211) 211
saccharomyces cerevisiae - genetics (209) 209
cell cycle proteins - metabolism (207) 207
mitosis (199) 199
anemia, sickle cell - drug therapy (195) 195
mitosis - drug effects (192) 192
in vitro techniques (188) 188
molecular sequence data (184) 184
nucleic acid synthesis inhibitors - pharmacology (181) 181
flow cytometry (180) 180
hela cells (180) 180
aged (170) 170
tumor cells, cultured (169) 169
dactinomycin - pharmacology (164) 164
lipoxygenase inhibitors - pharmacology (164) 164
analysis (163) 163
proteins (161) 161
ribonucleotide reductases - antagonists & inhibitors (158) 158
sickle cell anemia (158) 158
phenotype (151) 151
cancer (148) 148
cell line, tumor (147) 147
dna - metabolism (147) 147
cell cycle proteins - genetics (144) 144
hydroxyurea - adverse effects (142) 142
protein-serine-threonine kinases - metabolism (142) 142
genetic aspects (141) 141
adolescent (140) 140
science & technology - other topics (137) 137
gene expression (136) 136
multidisciplinary sciences (136) 136
base sequence (135) 135
cell nucleus - metabolism (135) 135
sickle cell disease (135) 135
drug synergism (134) 134
amino acid sequence (133) 133
radiation effects (132) 132
autoradiography (130) 130
models, biological (129) 129
bone marrow cells (128) 128
temperature (128) 128
dna-binding proteins - metabolism (127) 127
drug resistance (127) 127
cell differentiation - drug effects (126) 126
saccharomyces cerevisiae - drug effects (125) 125
hematopoietic stem cells - drug effects (123) 123
physiological aspects (122) 122
dna, neoplasm - biosynthesis (118) 118
saccharomyces cerevisiae proteins - metabolism (118) 118
mice, inbred c57bl (117) 117
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4844) 4844
Russian (80) 80
Japanese (45) 45
German (32) 32
French (30) 30
Chinese (19) 19
Polish (8) 8
Italian (6) 6
Portuguese (5) 5
Spanish (3) 3
Bulgarian (2) 2
Croatian (1) 1
Hebrew (1) 1
Hungarian (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cell (Cambridge), ISSN 0092-8674, 09/2007, Volume 130, Issue 5, pp. 797 - 810
Antibiotic mode-of-action classification is based upon drug-target interaction and whether the resultant inhibition of cellular function is lethal to bacteria.... 
SYSBIO | MICROBIO | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Free Radical Scavengers - pharmacology | Hydroxyurea - pharmacology | Escherichia coli - drug effects | Gene Expression Profiling | Colony Count, Microbial | DNA, Bacterial - drug effects | Norfloxacin - pharmacology | Time Factors | Carbon-Sulfur Lyases - genetics | Escherichia coli - metabolism | Ampicillin - pharmacology | Membrane Proteins - metabolism | Cell Death - drug effects | Escherichia coli - growth & development | Rec A Recombinases - genetics | NAD - metabolism | Staphylococcus aureus - metabolism | 2,2'-Dipyridyl - pharmacology | Staphylococcus aureus - genetics | Rec A Recombinases - metabolism | Microbial Viability - drug effects | Membrane Proteins - genetics | Citric Acid Cycle - drug effects | Escherichia coli Proteins - metabolism | Hydroxyl Radical - metabolism | Carbon-Sulfur Lyases - metabolism | Kanamycin - pharmacology | Hydrogen Peroxide - metabolism | Gene Expression Regulation, Bacterial - drug effects | Citric Acid Cycle - genetics | Anti-Bacterial Agents - classification | Iron Chelating Agents - pharmacology | Escherichia coli - genetics | Ferrous Compounds - metabolism | Escherichia coli Proteins - genetics | Anti-Bacterial Agents - pharmacology | DNA Damage | Mutation | Oxidative Stress - drug effects | Staphylococcus aureus - drug effects | Staphylococcus aureus - growth & development | Metabolites | Antibiotics | Index Medicus
Journal Article
Journal Article
BMC cancer, ISSN 1471-2407, 07/2016, Volume 16, Issue 1, pp. 458 - 458
Background: Endocannabinoids have recently drawn attention as promising anti-cancer agents. We previously observed that anandamide (AEA), one of the... 
DHEA | Head and neck cancer | Endocannabinoid | 5-lipoxygenase | NALA | ROS | Life Sciences & Biomedicine | Oncology | Science & Technology | Hydroxyurea - analogs & derivatives | Hydroxyurea - pharmacology | Phosphorylation | Alanine - therapeutic use | Reactive Oxygen Species - metabolism | Endocannabinoids - pharmacology | Apoptosis - drug effects | Humans | Antineoplastic Agents - therapeutic use | Carcinogenesis - metabolism | Organoselenium Compounds - pharmacology | Alanine - analogs & derivatives | TRPV Cation Channels - metabolism | Squamous Cell Carcinoma of Head and Neck | Piperidines - pharmacology | TRPV Cation Channels - antagonists & inhibitors | Antineoplastic Agents - pharmacology | Proto-Oncogene Proteins c-akt - metabolism | Alanine - pharmacology | Endocannabinoids - therapeutic use | Pyrazoles - pharmacology | Arachidonate 5-Lipoxygenase - metabolism | Signal Transduction | Head and Neck Neoplasms - drug therapy | Azoles - pharmacology | Arachidonic Acids - pharmacology | Benzoquinones - pharmacology | Receptor, Cannabinoid, CB1 - metabolism | Arachidonic Acids - therapeutic use | Carcinoma, Squamous Cell - drug therapy | Cell Line, Tumor | Cell Proliferation - drug effects | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Lipoxygenase Inhibitors - pharmacology | Antioxidants | Squamous cell carcinoma | Care and treatment | Dehydroepiandrosterone | Dosage and administration | Research | Health aspects | Cancer | Index Medicus
Journal Article
Journal Article
Eukaryotic Cell, ISSN 1535-9778, 03/2010, Volume 9, Issue 3, pp. 360 - 378
Classifications Services EC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
Life Sciences & Biomedicine | Microbiology | Mycology | Science & Technology | Hydroxyurea - pharmacology | ras Proteins - genetics | Cryptococcus neoformans - physiology | Gene Expression - drug effects | Gene Expression - genetics | Oxidative Stress - physiology | Cryptococcus neoformans - genetics | Drug Resistance, Fungal - physiology | ras Proteins - metabolism | Gene Expression Profiling | Gene Expression Regulation, Fungal - drug effects | Heat-Shock Proteins - genetics | Cell Wall - drug effects | Cyclic AMP-Dependent Protein Kinases - genetics | Cadmium Compounds - pharmacology | DNA Damage - physiology | Gene Expression Regulation, Fungal - physiology | Cell Cycle Proteins - genetics | Dioxoles - pharmacology | Stress, Physiological - drug effects | Cyclic AMP - metabolism | Osmotic Pressure - physiology | Antifungal Agents - pharmacology | DNA Damage - drug effects | Stress, Physiological - physiology | Pyruvaldehyde - pharmacology | Congo Red - pharmacology | Superoxides - pharmacology | Cell Wall - genetics | GTP-Binding Protein alpha Subunits - genetics | Up-Regulation - genetics | Signal Transduction - genetics | Sulfates - pharmacology | Drug Resistance, Fungal - genetics | Fungal Proteins - genetics | Mutation - genetics | Down-Regulation - genetics | Cryptococcus neoformans - drug effects | Pyrroles - pharmacology | Models, Biological | Adaptor Proteins, Signal Transducing - genetics | Signal Transduction - physiology | Oxidative Stress - drug effects | Adenylyl Cyclases - genetics | Methyl Methanesulfonate - pharmacology | Cluster Analysis | Index Medicus
Journal Article
PLoS biology, ISSN 1545-7885, 06/2017, Volume 15, Issue 6, pp. e2001644 - e2001644
Antibiotic-resistant infections kill approximately 23,000 people and cost $20,000,000,000 each year in the United States alone despite the widespread use of... 
Biochemistry & Molecular Biology | Biology | Life Sciences & Biomedicine - Other Topics | Life Sciences & Biomedicine | Science & Technology | Trimethoprim - chemistry | Klebsiella pneumoniae - drug effects | Escherichia coli - drug effects | Embryo, Nonmammalian - drug effects | Reverse Transcriptase Inhibitors - chemistry | Anti-Infective Agents, Urinary - therapeutic use | Biological Assay | Trimethoprim - agonists | Anti-Infective Agents, Urinary - chemistry | Anti-Infective Agents, Urinary - pharmacology | Escherichia coli Infections - drug therapy | Bacterial Proteins - antagonists & inhibitors | Computational Biology | Trimethoprim - therapeutic use | Mutation Rate | Escherichia coli Infections - metabolism | Drug Synergism | Small Molecule Libraries | Klebsiella pneumoniae - growth & development | Anti-Bacterial Agents - pharmacology | Mutation | Folic Acid Antagonists - pharmacology | Folic Acid Antagonists - chemistry | Trimethoprim - pharmacology | Sulfamethizole - agonists | Embryo, Nonmammalian - metabolism | Klebsiella Infections - metabolism | Reverse Transcriptase Inhibitors - pharmacology | Zebrafish - embryology | Folic Acid Antagonists - therapeutic use | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Sulfamethizole - chemistry | Anti-Bacterial Agents - chemistry | Drug Resistance, Multiple, Bacterial | Sulfamethizole - pharmacology | Drug Design | Escherichia coli - metabolism | Sulfamethizole - therapeutic use | Escherichia coli - growth & development | Klebsiella pneumoniae - metabolism | Reverse Transcriptase Inhibitors - therapeutic use | Drug Therapy, Combination | Klebsiella Infections - drug therapy | Bacterial Proteins - genetics | Escherichia coli Infections - microbiology | Embryo, Nonmammalian - microbiology | Klebsiella Infections - microbiology | Animals | High-Throughput Screening Assays | Bacterial Proteins - metabolism | Pattern Recognition, Automated | Prevention | Dosage and administration | Antibiotics | Drug resistance | Klebsiella | Virulence | Homeostasis | Trimethoprim | Hydroxyurea | Identification | Biosynthesis | Infections | Urinary tract | Drug development | Synergism | Folic acid | Design | Immunology | Historical account | E coli | New combinations | Antibiotic resistance | Bacteria | Libraries | Deoxyribonucleic acid--DNA | Effectiveness | Bacterial infections | Mutants | Medicine | DNA biosynthesis | Pathology | Sulfamethizole | Collection | Zidovudine | Bypasses | Methods | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
British journal of pharmacology, ISSN 0007-1188, 07/2001, Volume 133, Issue 6, pp. 920 - 926
Phagocytosis of unopsonized zymosan by RAW 264.7 macrophages upregulated protein expression of haem oxygenase‐1 (HO‐1), inducible nitric oxide synthase (iNOS)... 
nitric oxide | cyclo‐oxygenase‐2 | RAW 264.7 macrophages | 5‐lipoxygenase | Haem oxygenase‐1 | leukotrienes | inducible nitric oxide synthase | Cyclo-oxygenase-2 | Leukotrienes | Inducible nitric oxide synthase | Nitric oxide | 5-Lipoxygenase | Haem oxygenase-1 | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Hydroxyurea - analogs & derivatives | Prostaglandin-Endoperoxide Synthases - biosynthesis | Hydroxyurea - pharmacology | Cyclooxygenase 2 | Leukotrienes - pharmacology | Nitric Oxide Synthase - drug effects | Nitrites - metabolism | NF-kappa B - metabolism | Quinolones - pharmacology | Nitrobenzenes - pharmacology | Nitric Oxide Synthase Type II | Transcription Factor AP-1 - metabolism | Zymosan - pharmacology | Dose-Response Relationship, Drug | Dexamethasone - pharmacology | Heme Oxygenase (Decyclizing) - biosynthesis | Time Factors | Protein Binding - drug effects | Heme Oxygenase (Decyclizing) - drug effects | Heme Oxygenase-1 | Nitric Oxide Synthase - biosynthesis | Leukotriene C4 - pharmacology | Pyrans - pharmacology | NG-Nitroarginine Methyl Ester - pharmacology | Cell Line | Dinoprostone - pharmacology | Eicosanoids - pharmacology | Enzyme Inhibitors - pharmacology | Prostaglandin-Endoperoxide Synthases - drug effects | Macrophages - cytology | Sulfonamides - pharmacology | Chick Embryo | Indomethacin - pharmacology | Leukotriene B4 - pharmacology | Macrophages - metabolism | Animals | Macrophages - drug effects | Amidines - pharmacology | Isoenzymes - drug effects | Isoenzymes - biosynthesis | Macrophage Activation - drug effects | Nitric Oxide - metabolism | Benzylamines - pharmacology | Index Medicus | Papers | 5-lipoxygenase | cyclo-oxygenase-2
Journal Article